NCT02104947 Reversal of Dabigatran Anticoagulant Effect With Idarucizumab Status COMPLETED Phase PHASE3
NCT02102932 Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers Status COMPLETED Phase PHASE1
NCT02096744 Bioequivalence of Two Transdermal Clonidine Administrations in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02096731 Combined Bronchodilators in Chronic Obstructive Pulmonary Disease and the Risk of Adverse Cardio-pulmonary Events Status COMPLETED Phase N/A
NCT02093819 To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02085161 To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways Status COMPLETED Phase PHASE3
NCT02084511 Effectiveness and Safety of Different Doses of BI 1026706 in Patients With Postoperative Dental Pain Status COMPLETED Phase PHASE1
NCT02084082 Bioequivalence of a FDC Tablet of Linagliptin/Metformin (5mg/1000mg) Extended Release in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02084056 Bioequivalence of a FDC Tablet of Linagliptin/Metformin (2.5mg/1000mg) Extended Release in Healthy Subjects. Status COMPLETED Phase PHASE1
NCT02082548 Clinical Trial to Improve Treatment With Blood Thinners in Patients With Atrial Fibrillation Status COMPLETED Phase NA
NCT02081807 Sequential Expansion of Comparative Effectiveness of Anticoagulants Status COMPLETED Phase N/A
NCT02068690 Safety, Tolerability, and Pharmacokinetics of Single Doses BI 425809 Status COMPLETED Phase PHASE1
NCT02067182 Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation Status COMPLETED Phase PHASE4
NCT02061748 The Comparative Safety and Effectiveness of Warfarin and Dabigatran Prescribed in the Non-valvular Atrial Fibrillation Population With Humana Healthcare Coverage Status COMPLETED Phase N/A
NCT02057835 Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 691751 in Healthy Asian Male Volunteers Status COMPLETED Phase PHASE1
NCT02054481 BI 655066 Dose Ranging in Psoriasis, Active Comparator Ustekinumab Status COMPLETED Phase PHASE2
NCT02047903 GIOTRIF in First Line Therapy of Advanced NSCLC With EGFR-mutations Status COMPLETED Phase N/A
NCT02047110 BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS) Status COMPLETED Phase PHASE2